Preoperative serum C-reactive protein and gastric cancer; Clinical-pathological correlation and prognostic significance

Cheng Chih Chang, Chien Feng Sun, Hung Jia Pai, Wen Ke Wang, Ching Chuan Hsieh, Liang Mou Kuo, Chia Siu Wang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: C-reactive protein (CRP) is a widely-used systemic biomarker for inflammation. Serum CRP is elevated in many malignancies, and is also a prognostic indicator of malignant potential. However, the prognostic significance for survival from gastric cancer has not yet been clarified. We studied the clinical-pathologic association and prognostic significance of preoperative serum CRP in gastric cancer patients. Methods: A total of 170 gastric cancer patients were included in this study. The mean age of the patients was 65.1 years (range, 29-89), and 112 were men. All gastric cancer patients had undergone gastric resection. The serum CRP levels of patients before the operation along with those from 405 healthy controls were measured by a high sensitivity CRP test. Results: The 95th percentile value (= 3.0 mg/L) of the serum CRP data in 405 healthy controls was set as the upper cut-off value of the normal range. Abnormally high levels of serum CRP were observed in 65 (38.2%) of our 170 patients in contrast to only 20 (4.9%) of the 405 healthy controls (p < 0.001). Elevated CRP was associated with older age (p = 0.009), grossly infiltrative type (p = 0.001), larger tumors (p < 0.001), serosal invasion (p = 0.001), lymph node metastasis (p < 0.001), distant metastasis (p = 0.017), and lymphatic invasion (p = 0.002). Overall, a higher CRP level was strongly parallel to a pathologically more advanced stage (p = 0.001). The 5-yr survival rate of patients with an elevated (> 3.0 mg/L) CRP was significantly worse than those without (≤ 3.0 mg/L) (27.1% versus 54.1%, log rank p = 0.0010). Conclusion: The preoperative serum CRP level was abnormally elevated in 38.2% of gastric cancer patients. Elevated CRP was associated with progressive disease or an advanced stage, and a worse survival. Although serum CRP is not a specific biomarker for gastric cancer, it might be a potential prognostic biomarker and a promising therapeutic target for gastric cancer patients.

Original languageEnglish
Pages (from-to)301-312
Number of pages12
JournalChang Gung Medical Journal
Volume33
Issue number3
Publication statusPublished - Jan 1 2010
Externally publishedYes

Fingerprint

C-Reactive Protein
Stomach Neoplasms
Blood Proteins
Biomarkers
Survival
Stomach
Reference Values
Inflammation

Keywords

  • C-reactive protein
  • Gastric cancer
  • Inflammatory biomarker
  • Prognostic factor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chang, C. C., Sun, C. F., Pai, H. J., Wang, W. K., Hsieh, C. C., Kuo, L. M., & Wang, C. S. (2010). Preoperative serum C-reactive protein and gastric cancer; Clinical-pathological correlation and prognostic significance. Chang Gung Medical Journal, 33(3), 301-312.

Preoperative serum C-reactive protein and gastric cancer; Clinical-pathological correlation and prognostic significance. / Chang, Cheng Chih; Sun, Chien Feng; Pai, Hung Jia; Wang, Wen Ke; Hsieh, Ching Chuan; Kuo, Liang Mou; Wang, Chia Siu.

In: Chang Gung Medical Journal, Vol. 33, No. 3, 01.01.2010, p. 301-312.

Research output: Contribution to journalArticle

Chang, Cheng Chih ; Sun, Chien Feng ; Pai, Hung Jia ; Wang, Wen Ke ; Hsieh, Ching Chuan ; Kuo, Liang Mou ; Wang, Chia Siu. / Preoperative serum C-reactive protein and gastric cancer; Clinical-pathological correlation and prognostic significance. In: Chang Gung Medical Journal. 2010 ; Vol. 33, No. 3. pp. 301-312.
@article{55548050404d482db8725b0c6ad8f8df,
title = "Preoperative serum C-reactive protein and gastric cancer; Clinical-pathological correlation and prognostic significance",
abstract = "Background: C-reactive protein (CRP) is a widely-used systemic biomarker for inflammation. Serum CRP is elevated in many malignancies, and is also a prognostic indicator of malignant potential. However, the prognostic significance for survival from gastric cancer has not yet been clarified. We studied the clinical-pathologic association and prognostic significance of preoperative serum CRP in gastric cancer patients. Methods: A total of 170 gastric cancer patients were included in this study. The mean age of the patients was 65.1 years (range, 29-89), and 112 were men. All gastric cancer patients had undergone gastric resection. The serum CRP levels of patients before the operation along with those from 405 healthy controls were measured by a high sensitivity CRP test. Results: The 95th percentile value (= 3.0 mg/L) of the serum CRP data in 405 healthy controls was set as the upper cut-off value of the normal range. Abnormally high levels of serum CRP were observed in 65 (38.2{\%}) of our 170 patients in contrast to only 20 (4.9{\%}) of the 405 healthy controls (p < 0.001). Elevated CRP was associated with older age (p = 0.009), grossly infiltrative type (p = 0.001), larger tumors (p < 0.001), serosal invasion (p = 0.001), lymph node metastasis (p < 0.001), distant metastasis (p = 0.017), and lymphatic invasion (p = 0.002). Overall, a higher CRP level was strongly parallel to a pathologically more advanced stage (p = 0.001). The 5-yr survival rate of patients with an elevated (> 3.0 mg/L) CRP was significantly worse than those without (≤ 3.0 mg/L) (27.1{\%} versus 54.1{\%}, log rank p = 0.0010). Conclusion: The preoperative serum CRP level was abnormally elevated in 38.2{\%} of gastric cancer patients. Elevated CRP was associated with progressive disease or an advanced stage, and a worse survival. Although serum CRP is not a specific biomarker for gastric cancer, it might be a potential prognostic biomarker and a promising therapeutic target for gastric cancer patients.",
keywords = "C-reactive protein, Gastric cancer, Inflammatory biomarker, Prognostic factor",
author = "Chang, {Cheng Chih} and Sun, {Chien Feng} and Pai, {Hung Jia} and Wang, {Wen Ke} and Hsieh, {Ching Chuan} and Kuo, {Liang Mou} and Wang, {Chia Siu}",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "33",
pages = "301--312",
journal = "Chang Gung Medical Journal",
issn = "0255-8270",
publisher = "Chang Gung Medical Journal",
number = "3",

}

TY - JOUR

T1 - Preoperative serum C-reactive protein and gastric cancer; Clinical-pathological correlation and prognostic significance

AU - Chang, Cheng Chih

AU - Sun, Chien Feng

AU - Pai, Hung Jia

AU - Wang, Wen Ke

AU - Hsieh, Ching Chuan

AU - Kuo, Liang Mou

AU - Wang, Chia Siu

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Background: C-reactive protein (CRP) is a widely-used systemic biomarker for inflammation. Serum CRP is elevated in many malignancies, and is also a prognostic indicator of malignant potential. However, the prognostic significance for survival from gastric cancer has not yet been clarified. We studied the clinical-pathologic association and prognostic significance of preoperative serum CRP in gastric cancer patients. Methods: A total of 170 gastric cancer patients were included in this study. The mean age of the patients was 65.1 years (range, 29-89), and 112 were men. All gastric cancer patients had undergone gastric resection. The serum CRP levels of patients before the operation along with those from 405 healthy controls were measured by a high sensitivity CRP test. Results: The 95th percentile value (= 3.0 mg/L) of the serum CRP data in 405 healthy controls was set as the upper cut-off value of the normal range. Abnormally high levels of serum CRP were observed in 65 (38.2%) of our 170 patients in contrast to only 20 (4.9%) of the 405 healthy controls (p < 0.001). Elevated CRP was associated with older age (p = 0.009), grossly infiltrative type (p = 0.001), larger tumors (p < 0.001), serosal invasion (p = 0.001), lymph node metastasis (p < 0.001), distant metastasis (p = 0.017), and lymphatic invasion (p = 0.002). Overall, a higher CRP level was strongly parallel to a pathologically more advanced stage (p = 0.001). The 5-yr survival rate of patients with an elevated (> 3.0 mg/L) CRP was significantly worse than those without (≤ 3.0 mg/L) (27.1% versus 54.1%, log rank p = 0.0010). Conclusion: The preoperative serum CRP level was abnormally elevated in 38.2% of gastric cancer patients. Elevated CRP was associated with progressive disease or an advanced stage, and a worse survival. Although serum CRP is not a specific biomarker for gastric cancer, it might be a potential prognostic biomarker and a promising therapeutic target for gastric cancer patients.

AB - Background: C-reactive protein (CRP) is a widely-used systemic biomarker for inflammation. Serum CRP is elevated in many malignancies, and is also a prognostic indicator of malignant potential. However, the prognostic significance for survival from gastric cancer has not yet been clarified. We studied the clinical-pathologic association and prognostic significance of preoperative serum CRP in gastric cancer patients. Methods: A total of 170 gastric cancer patients were included in this study. The mean age of the patients was 65.1 years (range, 29-89), and 112 were men. All gastric cancer patients had undergone gastric resection. The serum CRP levels of patients before the operation along with those from 405 healthy controls were measured by a high sensitivity CRP test. Results: The 95th percentile value (= 3.0 mg/L) of the serum CRP data in 405 healthy controls was set as the upper cut-off value of the normal range. Abnormally high levels of serum CRP were observed in 65 (38.2%) of our 170 patients in contrast to only 20 (4.9%) of the 405 healthy controls (p < 0.001). Elevated CRP was associated with older age (p = 0.009), grossly infiltrative type (p = 0.001), larger tumors (p < 0.001), serosal invasion (p = 0.001), lymph node metastasis (p < 0.001), distant metastasis (p = 0.017), and lymphatic invasion (p = 0.002). Overall, a higher CRP level was strongly parallel to a pathologically more advanced stage (p = 0.001). The 5-yr survival rate of patients with an elevated (> 3.0 mg/L) CRP was significantly worse than those without (≤ 3.0 mg/L) (27.1% versus 54.1%, log rank p = 0.0010). Conclusion: The preoperative serum CRP level was abnormally elevated in 38.2% of gastric cancer patients. Elevated CRP was associated with progressive disease or an advanced stage, and a worse survival. Although serum CRP is not a specific biomarker for gastric cancer, it might be a potential prognostic biomarker and a promising therapeutic target for gastric cancer patients.

KW - C-reactive protein

KW - Gastric cancer

KW - Inflammatory biomarker

KW - Prognostic factor

UR - http://www.scopus.com/inward/record.url?scp=77954531058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954531058&partnerID=8YFLogxK

M3 - Article

C2 - 20584508

AN - SCOPUS:77954531058

VL - 33

SP - 301

EP - 312

JO - Chang Gung Medical Journal

JF - Chang Gung Medical Journal

SN - 0255-8270

IS - 3

ER -